Peri-operative management of anticoagulation and antiplatelet therapy

British Journal of Haematology

Volumn 175, Issue 4, 2016, Pages 602-613

  Keeling, David ^a   Tait, R Campbell ^b   Watson, Henry ^c   British Committee of Standards for Haematology, ^d  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d British Society for Haematology   (United Kingdom)

Author keywords

anticoagulation; antiplatelet; perioperative; surgery; warfarin

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANDEXANET ALFA; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; APIXABAN; CLOPIDOGREL; DABIGATRAN; DALTEPARIN; EDOXABAN; FLUINDIONE; IDARUCIZUMAB; LOW MOLECULAR WEIGHT HEPARIN; PHENINDIONE; PHENPROCOUMON; PLACEBO; PRASUGREL; PROTHROMBIN COMPLEX; RIVAROXABAN; TICAGRELOR; TRANEXAMIC ACID; WARFARIN;

ANTICOAGULANT THERAPY; ARTERIAL THROMBOEMBOLISM; ATRIAL FIBRILLATION; BLEEDING; BLOOD CLOTTING TEST; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; EMBOLISM; EMERGENCY SURGERY; EPIDURAL ANESTHESIA; ERYTHROCYTE TRANSFUSION; EVENING DOSAGE; HEART INFARCTION; HEMOSTASIS; HUMAN; LETTER; MECHANICAL HEART VALVE; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPINAL ANESTHESIA; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM; PROCEDURES;

ANTICOAGULANTS; GUIDELINES AS TOPIC; HUMANS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; WARFARIN;

EID: 84990996958     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14344     Document Type: Letter

References (75)

1. Ahmed, I. & Gertner, E. (2011) Safety of arthrocentesis in patients on chronic warfarin therapy with therapeutic INR. Journal of Hospital Medicine, 2, S1.
2. Ahmed, I., Gertner, E., Nelson, W.B., House, C.M., Dahiya, R., Anderson, C.P., Benditt, D.G. & Zhu, D.W.X. (2010) Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm: the Official Journal of the Heart Rhythm Society, 7, 745–749.
3. Airaksinen, K.E.J., Korkeila, P., Lund, J., Ylitalo, A., Karjalainen, P., Virtanen, V., Raatikainen, P., Koivisto, U.-M. & Koistinen, J. (2013) Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment–the FinPAC study. International Journal of Cardiology, 168, 3679–3682.
4. Albaladejo, P., Marret, E., Samama, C.-M., Collet, J.-P., Abhay, K., Loutrel, O., Charbonneau, H., Jaber, S., Thoret, S., Bosson, J.-L. & Piriou, V. (2011) Non-cardiac surgery in patients with coronary stents: the RECO study. Heart, 97, 1566–1572.
5. Baharoglu, M.I., Cordonnier, C., Salman, R.A., de Gans, K., Koopman, M.M., Brand, A., Majoie, C.B., Beenen, L.F., Marquering, H.A., Vermeulen, M., Nederkoorn, P.J., de Haan, R.J. & Roos, Y.B. (2016) Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet, 387, 2605–2613.
6. Baron, T.H., Kamath, P.S. & McBane, R.D. (2013) Management of antithrombotic therapy in patients undergoing invasive procedures. New England Journal of Medicine, 368, 2113–2124.
7. Biondi-Zoccai, G.G., Lotrionte, M., Agostoni, P., Abbate, A., Fusaro, M., Burzotta, F., Testa, L., Sheiban, I. & Sangiorgi, G. (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. European Heart Journal, 27, 2667–2674.
8. Burger, W., Chemnitius, J.M., Kneissl, G.D. & Rucker, G. (2005) Low-close aspirin for secondary cardiovascular prevention - Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - Review and meta-analysis. Journal of Internal Medicine, 257, 399–414.
9. Capodanno, D. & Angiolillo, D.J. (2013) Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation, 128, 2785–2798.
10. Chai-Adisaksopha, C., Hillis, C., Lim, W., Boonyawat, K., Moffat, K. & Crowther, M. (2015) Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. Journal of Thrombosis and Haemostasis, 13, 1790–1798.
11. Chang, D.N., Dager, W.E. & Chin, A.I. (2013) Removal of dabigatran by hemodialysis. American Journal of Kidney Diseases, 61, 487–489.
12. Corredor, C., Wasowicz, M., Karkouti, K. & Sharma, V. (2015) The role of point-of-care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta-analysis. Anaesthesia, 70, 715–731.
13. Dentali, F., Pignatelli, P., Malato, A., Poli, D., Di Minno, M.N., Di Gennaro, L., Rancan, E., Pastori, D., Grifoni, E., Squizzato, A., Siragusa, S., Di Minno, G. & Ageno, W. (2012) Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. American Journal of Hematology, 87, 384–387.
14. Devereaux, P.J., Mrkobrada, M., Sessler, D.I., Leslie, K., Alonso-Coello, P., Kurz, A., Villar, J.C., Sigamani, A., Biccard, B.M., Meyhoff, C.S., Parlow, J.L., Guyatt, G., Robinson, A., Garg, A.X., Rodseth, R.N., Botto, F., Lurati Buse, G., Xavier, D., Chan, M.T.V., Tiboni, M., Cook, D., Kumar, P.A., Forget, P., Malaga, G., Fleischmann, E., Amir, M., Eikelboom, J., Mizera, R., Torres, D., Wang, C.Y., VanHelder, T., Paniagua, P., Berwanger, O., Srinathan, S., Graham, M., Pasin, L., Le Manach, Y., Gao, P., Pogue, J., Whitlock, R., Lamy, A., Kearon, C., Baigent, C., Chow, C., Pettit, S., Chrolavicius, S., Yusuf, S. & Investigators, P. (2014) Aspirin in patients undergoing noncardiac surgery. New England Journal of Medicine, 370, 1494–1503.
15. Douketis, J.D., Spyropoulos, A.C., Spencer, F.A., Mayr, M., Jaffer, A.K., Eckman, M.H., Dunn, A.S. & Kunz, R. (2012) Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e326S–e350S.
16. Douketis, J.D., Spyropoulos, A.C., Kaatz, S., Becker, R.C., Caprini, J.A., Dunn, A.S., Garcia, D.A., Jacobson, A., Jaffer, A.K., Kong, D.F., Schulman, S., Turpie, A.G., Hasselblad, V. & Ortel, T.L. (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. New England Journal of Medicine, 373, 823–833.
17. Dunn, A.S. & Turpie, A.G. (2003) Perioperative management of patients receiving oral anticoagulants: a systematic review. Archives of Internal Medicine, 163, 901–908.
18. Dunn, A.S., Spyropoulos, A.C. & Turpie, A.G. (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). Journal of Thrombosis and Haemostasis, 5, 2211–2218.
19. Eijgenraam, P., Ten Cate, H. & Ten Cate-Hoek, A. (2013) Safety and efficacy of bridging with low molecular weight heparins: a systematic review. Journal of Thrombosis and Haemostasis, 11, 13.
20. Ferraris, V.A., Saha, S.P., Oestreich, J.H., Song, H.K., Rosengart, T., Reece, T.B., Mazer, C.D., Bridges, C.R., Despotis, G.J., Jointer, K. & Clough, E.R. (2012) 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Annals of Thoracic Surgery, 94, 1761–1781.
21. Garcia, D., Alexander, J.H., Wallentin, L., Wojdyla, D.M., Thomas, L., Hanna, M., Al-Khatib, S.M., Dorian, P., Ansell, J., Commerford, P., Flaker, G., Lanas, F., Vinereanu, D., Xavier, D., Hylek, E.M., Held, C., Verheugt, F.W.A., Granger, C.B. & Lopes, R.D. (2014) Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood, 124, 3692–3698.
22. Godier, A., Taylor, G. & Gaussem, P. (2015) Inefficacy of platelet transfusion to reverse ticagrelor. New England Journal of Medicine, 372, 196–197.
23. Goldstein, J.N., Refaai, M.A., Milling, T.J. Jr, Lewis, B., Goldberg-Alberts, R., Hug, B.A. & Sarode, R. (2015) Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet, 385, 2077–2087.
24. Hansson, E.C., Shams Hakimi, C., Astrom-Olsson, K., Hesse, C., Wallen, H., Dellborg, M., Albertsson, P. & Jeppsson, A. (2014) Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. British Journal of Anaesthesia, 112, 570–575.
25. Hastings, S., Myles, P. & McIlroy, D. (2015) Aspirin and coronary artery surgery: a systematic review and meta-analysis. British Journal of Anaesthesia, 115, 376–385.
26. Healey, J.S., Eikelboom, J., Douketis, J., Wallentin, L., Oldgren, J., Yang, S., Themeles, E., Heidbuchel, H., Avezum, A., Reilly, P., Connolly, S.J., Yusuf, S. & Ezekowitz, M. (2012) Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation, 126, 343–348.
27. Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H.C., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A.J. & Kirchhof, P. (2015) Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace, 17, 1467–1507.
28. Held, C., Asenblad, N., Bassand, J.P., Becker, R.C., Cannon, C.P., Claeys, M.J., Harrington, R.A., Horrow, J., Husted, S., James, S.K., Mahaffey, K.W., Nicolau, J.C., Scirica, B.M., Storey, R.F., Vintila, M., Ycas, J. & Wallentin, L. (2011) Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. Journal of the American College of Cardiology, 57, 672–684.
29. Horlocker, T.T., Wedel, D.J., Rowlingson, J.C., Enneking, F.K., Kopp, S.L., Benzon, H.T., Brown, D.L., Heit, J.A., Mulroy, M.F., Rosenquist, R.W., Tryba, M. & Yuan, C.S. (2010) Regional Anesthesia in the patient receiving antithrombotic or thrombolytic therapy; American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (Third Edition). Regional Anesthesia and Pain Medicine, 35, 64–101.
30. Jamula, E., Anderson, J. & Douketis, J.D. (2009) Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis. Thrombosis Research, 124, 292–299.
31. Kaatz, S., Douketis, J.D., White, R.H. & Zhou, H. (2011) Can the CHADS2 score predict postoperative stroke risk in patients with chronic atrial fibrillation who are having elective non-cardiac surgery? Journal of Thrombosis and Haemostasis, 9, 635.
32. Kasivisvanathan, R., Abbassi-Ghadi, N., Kumar, S., Mackenzie, H., Thompson, K., James, K. & Mallett, S.V. (2014) Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery. British Journal of Surgery, 101, 1383–1390.
33. Kearon, C. & Akl, E.A. (2014) Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood, 123, 1794–1801.
34. Kearon, C. & Hirsh, J. (1997) Management of anticoagulation before and after elective surgery. New England Journal of Medicine, 336, 1506–1511.
35. Keeling, D., Baglin, T., Tait, C., Watson, H., Perry, D., Baglin, C., Kitchen, S. & Makris, M. (2011) Guidelines on oral anticoagulation with warfarin - fourth edition. British Journal of Haematology, 154, 311–324.
36. Kitchen, S., Gray, E., Mackie, I., Baglin, T. & Makris, M. (2014) Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology. British Journal of Haematology, 166, 830–841.
37. Korte, W., Cattaneo, M., Chassot, P.G., Eichinger, S., von Heymann, C., Hofmann, N., Rickli, H., Spannagl, M., Ziegler, B., Verheugt, F. & Huber, K. (2011) Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thrombosis & Haemostasis, 105, 743–749.
38. Kunadian, B., Thornley, A.R., Tanos, M. & Dunning, J. (2006) Should clopidogrel be stopped prior to urgent cardiac surgery? Interactive Cardiovascular and Thoracic Surgery, 5, 630–636.
39. Kwak, Y.L., Kim, J.C., Choi, Y.S., Yoo, K.J., Song, Y. & Shim, J.K. (2010) Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. Journal of the American College of Cardiology, 56, 1994–2002.
40. Lai, A., Davidson, N., Galloway, S.W. & Thachil, J. (2014) Perioperative management of patients on new oral anticoagulants.[Erratum appears in Br J Surg. 2014 Nov; 101(12):1624]. British Journal of Surgery, 101, 742–749.
41. Li, C., Hirsh, J., Xie, C., Johnston, M.A. & Eikelboom, J.W. (2012) Reversal of the anti-platelet effects of aspirin and clopidogrel. Journal of Thrombosis and Haemostasis, 10, 521–528.
42. Luckie, M., Khattar, R.S. & Fraser, D. (2009) Non-cardiac surgery and antiplatelet therapy following coronary artery stenting. Heart, 95, 1303–1308.
43. Makris, M. (2014) Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now? Journal of Thrombosis and Haemostasis, 12, 1425–1427.
44. Mantz, J., Samama, C.M., Tubach, F., Devereaux, P.J., Collet, J.P., Albaladejo, P., Cholley, B., Nizard, R., Barre, J., Piriou, V., Poirier, N., Mignon, A., Schlumberger, S., Longrois, D., Aubrun, F., Farese, M.E., Ravaud, P. & Steg, P.G.; Stratagem Study Group. (2011) Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. British Journal of Anaesthesia, 107, 899–910.
45. McIlroy, D.R., Myles, P.S., Phillips, L.E. & Smith, J.A. (2009) Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis. British Journal of Anaesthesia, 102, 168–178.
46. Mehran, R., Baber, U., Steg, P.G., Ariti, C., Weisz, G., Witzenbichler, B., Henry, T.D., Kini, A.S., Stuckey, T., Cohen, D.J., Berger, P.B., Iakovou, I., Dangas, G., Waksman, R., Antoniucci, D., Sartori, S., Krucoff, M.W., Hermiller, J.B., Shawl, F., Gibson, C.M., Chieffo, A., Alu, M., Moliterno, D.J., Colombo, A. & Pocock, S. (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet, 382, 1714–1722.
47. Myles, P.S., Smith, J.A., Forbes, A., Silbert, B., Jayarajah, M., Painter, T., Cooper, D.J., Marasco, S., McNeil, J., Bussieres, J.S. & Wallace, S. (2016) Stopping vs. Continuing Aspirin before Coronary Artery Surgery. New England Journal of Medicine, 374, 728–737.
48. Narouze, S., Benzon, H.T., Provenzano, D.A., Buvanendran, A., De Andres, J., Deer, T.R., Rauck, R. & Huntoon, M.A. (2015) Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Regional Anesthesia and Pain Medicine, 40, 182–212.
49. Nuttall, G.A., Brown, M.J., Stombaugh, J.W., Michon, P.B., Hathaway, M.F., Lindeen, K.C., Hanson, A.C., Schroeder, D.R., Oliver, W.C., Holmes, D.R. & Rihal, C.S. (2008) Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology, 109, 588–595.
50. Oscarsson, A., Gupta, A., Fredrikson, M., Jarhult, J., Nystrom, M., Pettersson, E., Darvish, B., Krook, H., Swahn, E. & Eintrei, C. (2010) To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. British Journal of Anaesthesia, 104, 305–312.
51. Perry, D.J., Noakes, T.J. & Helliwell, P.S. (2007) Guidelines for the management of patients on oral anticoagulants requiring dental surgery. British Dental Journal, 203, 389–393.
52. Pollack, C.V. Jr, Reilly, P.A., Eikelboom, J., Glund, S., Verhamme, P., Bernstein, R.A., Dubiel, R., Huisman, M.V., Hylek, E.M., Kamphuisen, P.W., Kreuzer, J., Levy, J.H., Sellke, F.W., Stangier, J., Steiner, T., Wang, B., Kam, C.W. & Weitz, J.I. (2015) Idarucizumab for Dabigatran Reversal. New England Journal of Medicine, 373, 511–520.
53. Ranucci, M., Baryshnikova, E., Soro, G., Ballotta, A., De Benedetti, D. & Conti, D. (2011) Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Annals of Thoracic Surgery, 91, 123–129.
54. Refaai, M.A., Goldstein, J.N., Milling, T.J. Jr, Lewis, B., Goldberg-Alberts, R., Hug, B.A. & Sarode, R. (2013) Randomized phase IIIb study of rapid vitamin K antagonist reversal in patients requiring an urgent surgical procedure: Four-factor prothrombin complex concentrate is superior to plasma. Blood (ASH Annual Meeting Abstracts), 122, 3588.
55. Rossini, R., Musumeci, G., Visconti, L.O., Bramucci, E., Castiglioni, B., De Servi, S., Lettieri, C., Lettino, M., Piccaluga, E., Savonitto, S., Trabattoni, D., Capodanno, D., Buffoli, F., Parolari, A., Dionigi, G., Boni, L., Biglioli, F., Valdatta, L., Droghetti, A., Bozzani, A., Setacci, C., Ravelli, P., Crescini, C., Staurenghi, G., Scarone, P., Francetti, L., D'Angelo, F., Gadda, F., Comel, A., Salvi, L., Lorini, L., Antonelli, M., Bovenzi, F., Cremonesi, A., Angiolillo, D.J. & Guagliumi, G. (2014) Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention, 10, 38–46.
56. Rossini, R., Musumeci, G., Capodanno, D., Lettieri, C., Limbruno, U., Tarantini, G., Russo, N., Calabria, P., Romano, M., Inashvili, A., Sirbu, V., Guagliumi, G., Valsecchi, O., Senni, M., Gavazzi, A. & Angiolillo, D.J. (2015) Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery: results of a multicentre registry. Thrombosis and Haemostasis, 113, 272–282.
57. Savonitto, S., Caracciolo, M., Cattaneo, M. & De Servi, S. (2011) Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. Journal of Thrombosis & Haemostasis, 9, 2133–2142.
58. Schulman, S., Hwang, H.G., Eikelboom, J.W., Kearon, C., Pai, M. & Delaney, J. (2014) Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial. Journal of Thrombosis and Haemostasis, 12, 1254–1259.
59. Schulman, S., Carrier, M., Lee, A.Y., Shivakumar, S., Blostein, M., Spencer, F.A., Solymoss, S., Barty, R., Wang, G., Heddle, N. & Douketis, J.D.; Periop Dabigatran Study Group. (2015) Perioperative Management of Dabigatran: A Prospective Cohort Study. Circulation, 132, 167–173.
60. Shakur, H., Roberts, I., Bautista, R., Caballero, J., Coats, T., Dewan, Y., El-Sayed, H., Gogichaishvili, T., Gupta, S., Herrera, J., Hunt, B., Iribhogbe, P., Izurieta, M., Khamis, H., Komolafe, E., Marrero, M.A., Mejia-Mantilla, J., Miranda, J., Morales, C., Olaomi, O., Olldashi, F., Perel, P., Peto, R., Ramana, P.V., Ravi, R.R. & Yutthakasemsunt, S. (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 376, 23–32.
61. Sherwood, M.W., Douketis, J.D., Patel, M.R., Piccini, J.P., Hellkamp, A.S., Lokhnygina, Y., Spyropoulos, A.C., Hankey, G.J., Singer, D.E., Nessel, C.C., Mahaffey, K.W., Fox, K.A., Califf, R.M. & Becker, R.C. (2014) Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation, 129, 1850–1859.
62. Shi, J., Ji, H., Ren, F., Wang, G., Xu, M., Xue, Y., Chen, M., Qi, J. & Li, L. (2013) Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. JAMA Surgery, 148, 538–547.
63. Siegal, D., Yudin, J., Kaatz, S., Douketis, J.D., Lim, W. & Spyropoulos, A.C. (2012) Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation, 126, 1630–1639.
64. Siegal, D.M., Curnutte, J.T., Connolly, S.J., Lu, G., Conley, P.B., Wiens, B.L., Mathur, V.S., Castillo, J., Bronson, M.D., Leeds, J.M., Mar, F.A., Gold, A. & Crowther, M.A. (2015) Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. New England Journal of Medicine, 373, 2413–2424.
65. Singla, S., Sachdeva, R. & Uretsky, B.F. (2012) The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. Journal of the American College of Cardiology, 60, 2005–2016.
66. Smith, P.K., Goodnough, L.T., Levy, J.H., Poston, R.S., Short, M.A., Weerakkody, G.J. & Lenarz, L.A. (2012) Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. Journal of the American College of Cardiology, 60, 388–396.
67. Soo, C.G., Torre, P.K., Yolland, T.J. & Shatwell, M.A. (2016) Clopidogrel and hip fractures, is it safe? A systematic review and meta-analysis. BMC Musculoskeletal Disorders, 17, 136.
68. Sorensen, R., Hansen, M.L., Abildstrom, S.Z., Hvelplund, A., Andersson, C., Jorgensen, C., Madsen, J.K., Hansen, P.R., Kober, L., Torp-Pedersen, C. & Gislason, G.H. (2009) Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet, 374, 1967–1974.
69. Sousa-Uva, M., Storey, R., Huber, K., Falk, V., Leite-Moreira, A.F., Amour, J., Al-Attar, N., Ascione, R., Taggart, D. & Collet, J.P. (2014) Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. European Heart Journal, 35, 1510–1514.
70. Spyropoulos, A.C. & Douketis, J.D. (2012) How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood, 120, 2954–2962.
71. Steib, A., Barre, J., Mertes, M., Morel, M.H., Nathan, N., Ozier, Y., Treger, M. & Samama, C.M. (2010) Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists? Journal of Thrombosis & Haemostasis, 8, 499–503.
72. Thiele, T., Sumnig, A., Hron, G., Muller, C., Althaus, K., Schroeder, H.W. & Greinacher, A. (2012) Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. Journal of Thrombosis and Haemostasis, 10, 968–971.
73. Veitch, A.M., Vanbiervliet, G., Gershlick, A.H., Boustiere, C., Baglin, T.P., Smith, L.A., Radaelli, F., Knight, E., Gralnek, I.M., Hassan, C. & Dumonceau, J.M. (2016) Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut, 65, 374–389.
74. Vilahur, G., Choi, B.G., Zafar, M.U., Viles-Gonzalez, J.F., Vorchheimer, D.A., Fuster, V. & Badimon, J.J. (2007) Normalization of platelet reactivity in clopidogrel-treated subjects. Journal of Thrombosis & Haemostasis, 5, 82–90.
75. Ward, C., Conner, G., Donnan, G., Gallus, A. & McRae, S. (2013) Practical management of patients on apixaban: a consensus guide. Thrombosis Journal, 11, 27.